2026. Outcome of Combined Temozolomide/CCNU versus Temozolomide (Standard or Extended) For Patients with Methylated MGMT Glioblastoma. Journal of Cancer Research Updates. 15, 3 (Jul. 2026), 197–205. DOI:https://doi.org/10.30683/1929-2279.2026.15.18.